Bionyra Pharma Secures, 143 Million to Scale Inflammatory Disease Biologics

The biotech landscape continues to demonstrate resilience in securing large-scale venture capital, as evidenced by the launch of Bionyra Pharma. With a dual presence in Paris and Boston, the company has successfully closed an oversubscribed, 143 million…